Abstract
Tumor necrosis factor (TNF-alpha) is involved in the inflammation and tissue regeneration occurring after spinal cord injury (SCI). This study tests the specific role of p55 and p75 receptors in mediating the transport of TNF-alpha across the blood-spinal cord barrier (BSCB) after SCI by compression. Transcytosis of 125I-TNF-alpha across a monolayer of the cerebral endothelial cells that compose the blood-brain barrier was significantly reduced in the absence of functional p55 and p75 receptors. At 3 d after SCI, double receptor knockout mice had a significantly reduced increase in TNF-alpha uptake from blood to injured lumbar spinal cord as compared with their inbred controls, despite the similar extent of BSCB disruption (measured by 99mTc-albumin). The p75 single receptor knockout mice had a reduced increase in 125I-TNF-alpha uptake, whereas the p55 receptor knockout mice had no significant increase of 125I-TNF-alpha uptake after SCI, suggesting that the p55 receptor plays a major role. Hence, the increased uptake of TNF-alpha 3 d after SCI is not explained by nonspecific barrier disruption but by receptor-mediated upregulation of transport. Quantitative RT-PCR analysis further showed that upregulation of TNF-alpha transport was related to increased expression of mRNA for p55 and p75 receptors. The increase of p55 receptor expression was more robust and seen between 12 h and 1 wk after SCI, whereas the increase of p75 receptor expression occurred later and involved fewer regions. Thus, the differential upregulation of p55 and p75 receptors indicates that permeation of TNF-alpha across the injured BSCB remains a regulated process. Knowledge of receptor-mediated regulation could facilitate effective therapeutic manipulation of BSCB permeation of vascular cytokines important to CNS regeneration.
MeSH Terms
Animals
Animals, Outbred Strains
Antigens, CD/genetics,metabolism
Blood-Brain Barrier/physiology
Down-Regulation/genetics
Genes, Regulator/genetics
Iodine Radioisotopes
Mice
Mice, Inbred C57BL
Mice, Knockout
Myelitis/drug therapy,metabolism,physiopathology
Protein Transport/genetics
RNA, Messenger/metabolism
Receptors, Tumor Necrosis Factor/deficiency,genetics,metabolism
Receptors, Tumor Necrosis Factor, Type I
Receptors, Tumor Necrosis Factor, Type II
Spinal Cord Injuries/drug therapy,metabolism,physiopathology
Tumor Necrosis Factor-alpha/metabolism
Up-Regulation/genetics
Chemicals
Antigens, CD
Iodine Radioisotopes
RNA, Messenger
Receptors, Tumor Necrosis Factor
Receptors, Tumor Necrosis Factor, Type I
Receptors, Tumor Necrosis Factor, Type II
Tumor Necrosis Factor-alpha
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pan Weihong
Department of Medicine, Tulane University Health Science Center and the VA Medical Center, New Orleans, Louisiana 70112-1262, USA. wpan@tulane.edu
Csernus Balazs
Kastin Abba J
References (26)
26 references, click to expand
-
Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.
Am J Pathol. 1988 Dec;133(3):426-33
PMID: 2462353
-
The blood-spinal cord barrier after injury: pattern of vascular events proximal and distal to a transection in the rat.
Brain Res. 1987 Oct 20;424(1):177-88
PMID: 3690298
-
Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
J Neurotrauma. 1999 Oct;16(10):851-63
PMID: 10547095
-
TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice.
Exp Neurol. 2002 Apr;174(2):193-200
PMID: 11922661
-
Spinal cord compression injury in guinea pigs: structural changes of endothelium and its perivascular cell associations after blood-brain barrier breakdown and repair.
Exp Neurol. 1997 Apr;144(2):381-99
PMID: 9168838
-
Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
Exp Neurol. 1997 Aug;146(2):367-73
PMID: 9270046
-
Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury.
Exp Neurol. 2000 Nov;166(1):190-5
PMID: 11031095
-
Tumor necrosis factor-alpha: a neuromodulator in the CNS.
Neurosci Biobehav Rev. 1997 Sep;21(5):603-13
PMID: 9353794
-
TNF signaling in vascular endothelial cells.
Exp Mol Pathol. 2001 Jun;70(3):317-25
PMID: 11418010
-
Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
J Neurosci. 2000 May 15;20(10 ):3622-30
PMID: 10804204
-
Effects of pro-inflammatory cytokines in experimental spinal cord injury.
Brain Res. 1997 Jul 11;762(1-2):173-84
PMID: 9262171
-
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.
J Neuroimmunol. 1993 Sep;47(2):169-76
PMID: 8370768
-
Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury.
J Neurosci. 1999 May 1;19(9):3649-55
PMID: 10212323
-
TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1.
J Immunol. 1999 Jan 15;162(2):1042-8
PMID: 9916731
-
Upregulation of the transport system for TNFalpha at the blood-brain barrier.
Arch Physiol Biochem. 2001 Oct;109(4):350-3
PMID: 11935370
-
Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets.
Neurosci Lett. 1992 Dec 14;148(1-2):137-40
PMID: 1300486
-
Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion.
Exp Neurol. 2001 Aug;170(2):357-63
PMID: 11476601
-
Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury.
J Neurosci. 2001 Sep 1;21(17 ):6617-25
PMID: 11517251
-
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.
J Immunol. 1996 Apr 15;156(8):3017-23
PMID: 8609424
-
Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier.
Neuroscience. 1999;93(4):1449-64
PMID: 10501470
-
Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha.
Am J Physiol. 1996 Oct;271(4 Pt 1):E636-42
PMID: 8897850
-
Cytokines modulate the inflammatory response and change permissiveness to neuronal adhesion in injured mammalian central nervous system.
Exp Neurol. 1994 Apr;126(2):284-90
PMID: 7925826
-
Tumour necrosis factor signal transduction.
Cell Signal. 1990;2(1):1-8
PMID: 2176798
-
Permeability of the blood-brain and blood-spinal cord barriers to interferons.
J Neuroimmunol. 1997 Jun;76(1-2):105-11
PMID: 9184639
-
Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells.
J Immunol. 1993 Jun 15;150(12):5544-55
PMID: 8390537
-
Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury.
J Neurotrauma. 2000 Mar;17(3):203-18
PMID: 10757326